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In this Journal, Lange et al. describe the use of exercise
echocardiography to identify pulmonary hypertension in the
presence of an atrial septal defect (ASD) [1].
Atrial septal defect
An ASD is a relatively common congenital heart disease
with a birth prevalence of 1.6 per 1000 live births, and a
probability of survival into adulthood of 97 % [2, 3]. Different
types of ASDs exist, and the secundum type, located at the
fossa ovalis, is the most common (75 %) [4]. An ASD is
characterised by a left-to-right shunt with volume overload
of the right heart and pulmonary overcirculation. This might
result in arrhythmias, right heart failure, pulmonary arterial
hypertension, and paradoxical embolism, the last mentioned
due to a right-to-left shunt. Echocardiography is the primary
diagnostic technique, and cardiac catheterisation is required
in cases of a suspected increase in pulmonary artery pres-
sure (PAP). Indication for ASD closure is the presence of a
significant shunt with signs of right ventricular volume
overload without the presence of a severely increased pulmo-
nary vascular resistance (PVR) (<5 Woods units) [5]. Percu-
taneous closure has become the first choice of treatment for
secundum-type ASDs. Severe complications occurred in less
than 1 % [6].
Pulmonary hypertension
Pulmonary hypertension (PH) is a haemodynamic state
characterised by a mean PAP at rest of at least 25 mmHg
assessed by right heart catheterisation, and can be found in
multiple clinical conditions [7]. The two most common are
lung and left-sided heart diseases. Pulmonary arterial hyper-
tension (PAH) is a clinical condition with pre-capillary PH,
defined as PH with a normal wedge pressure and cardiac
output [7]. Congenital heart diseases with a systemic-to-
pulmonary shunt are associated with PAH. The histopatho-
logical changes found in this subgroup, such as endothelial
dysfunction and vascular remodelling with proliferative
changes, are similar to those observed in idiopathic or other
associated forms of PAH. Transthoracic echocardiography is
used to estimate the presence of PH based on the tricuspid
regurgitation peak velocity and additional characteristics
suggestive for PH. Over- and under-estimation of the sys-
tolic PAP can occur frequently [8]. The presence of PH is
likely if the systolic PAP is estimated at >50 mmHg with
or without additional findings [7]. Exercise echocardiography
is not recommended by the current PH guideline [7]. In
addition, exercise causes an increase in mean PAP of up to
3 mmHg per 1 l/min increase in cardiac output in healthy
individuals, and this is related to age and gender [9, 10]. The
definite diagnosis of PAH should always be confirmed by
right heart catheterisation.
Pulmonary hypertension and ASD
Pulmonary arterial hypertension is noted in 9 to 35 % of
patient with a secundum type ASD, both open and closed
[11, 12]. The definition of PH differs among the different
epidemiological studies. Predictors for the occurrence of
PAH are age, size of the defect, non-closed status, and
female sex [12, 13]. Pulmonary vascular disease related to
the systemic-to-pulmonary shunt might be prevented by
early correction of the defect in most patients. The window
of opportunity for correction and prevention of PAH is
lesion specific (pre- or post-tricuspid) and pulmonary vascular
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changes might still be reversible following closure. In the
presence of PAH, ASD closure can be favourable if the PVR
or PAP is less than two-thirds of the systemic measure-
ments at baseline or after vasodilator challenge [5]. If the
shunt has been reversed and Eisenmenger syndrome has
developed, closure of the ASD is contraindicated and PAH-
specific therapy should be started if the functional capacity
is decreased [7].
In the study by Lange et al. 59 ‘asymptomatic’ patients, with
haemodynamically relevant primum and secundum type ASD
(shunt fraction 1.7), were included [1]. Twenty-four percent
suffered from atrial fibrillation and three patients had a history
of stroke. Based on echocardiography, the authors stated that
PH was present in 45 % of the patients. However, the tricuspid
regurgitation peak velocity could only be measured in 83 %
and additional characteristics for the presence of PH were not
mentioned. Interestingly, the pulmonary haemodynamics (PAP
and PVR) were completely normal when assessed by right
heart catheterisation. This emphasises the role of echocardio-
graphy as a screening tool for PH, and that a definite diagnosis
should only be made by right heart catheterisation. Further-
more, they selected ‘ad random’ 27 out of 48 patients with
normal to moderately elevated pulmonary pressures for stress
echocardiography and described a significant increase in the
estimated PAP during exercise. Unfortunately, the cardiac
output and baseline characteristics of this subgroup were not
mentioned. As expected, the right ventricular parameters
improved and the PAP, estimated by TTE, decreased after
ASD closure.
Conclusion
Pulmonary hypertension can occur in the presence of an
ASD, and might be suspected by echocardiography. Currently,
exercise echocardiography is not recommended for diagnosing
PAH. The presence of PAH should always be confirmed by
right heart catheterisation. The pulmonary haemodynamics
and right ventricular function can improve after shunt closure.
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